Tag archive for ‘Phillip Frost’

OPKO buying Bio-Reference Laboratories for $1.5 billion

Opko Health Inc. (NYSE: OPK; TASE: OPK), has agreed to buy Bio-Reference Laboratories Inc.(Nasdaq: BRLI) in a deal valued at about $1.5 billion. Opko said it will pay 2.75 shares for each Bio-Reference Labs More...

Ilan Shavit On Wednesday, May 6th, 2015

Phillip Frost’s OPKO Health Acquires EirGen Pharma for $135 million in cash and shares

  Opko Health (NYSE: OPK; TASE: OPK), controlled by chairman Dr. Phillip Frost,  has acquired EirGen Pharma, Ltd., a pharmaceutical company based in Ireland,  focused on the development and More...

Tali Tsipori On Tuesday, May 5th, 2015

Benny Landa: Teva would be wrong to buy Mylan

Benny Landa feels confused. The successful entrepreneur, one of the fathers of Israel’s digital printing equipment industry, does not quite understand why Israel’s Teva Pharmaceutical Industries More...

Gali Weinreb On Monday, November 10th, 2014

Phillip Frost seeks SciGen reverse merger

–  The Opko Health Chairman hopes to attain a value of over $100 million for the Rehovot-based vaccination developer.   Vaccination company SciGen, controlled by Opko Health Inc. (NYSE: OPK; TASE: More...

Gil Tanenbaum On Thursday, August 7th, 2014

Patricia and Phillip Frost Museum of Science Nearing Completion in Miami

– Construction continues as planned on the new Patricia and Phillip Frost Museum of Science in Miami, which is scheduled to open in 2015. The Frosts endowed the 60 year old museum with $35 million of More...

Gil Tanenbaum On Tuesday, July 15th, 2014

Teva Pharmaceuticals Denies Picking New Chairman

– Entrepreneur and shareholder Benny Landa continues to cause trouble for Teva. – Israel’s largest company and the world’s largest manufacturer of generic medications, pharmaceutical giant More...

Shiri Habib-Valdhorn On Wednesday, June 18th, 2014

Teva’s old guard to leave board

– Chaim Hurvitz and Dan Suesskind will step down and Chairman Phillip Frost will leave before the end of the year. – – Chaim Hurvitz, the son of former Teva Pharmaceutical Industries More...

Moshe Golan On Wednesday, April 16th, 2014

Opko health turns Prolor Biologics into Israeli R&D, investment arm

– Chairman Phillip Frost: We have big plans for Opko Biologics. – Opko Health Inc. (NYSE: OPK; TASE: OPK) has renamed Prolor Biotech, which it acquired for $480 million a year ago, as Opko More...

Gali Weinreb On Tuesday, March 4th, 2014

Opko Health Losses Triple

– Chairman and CEO Phillip Frost: From an R&D perspective, all our programs are progressing. – – – Opko Health Inc. (NYSE: OPK; TASE: OPK) reported higher full-year and fourth More...

Globes On Wednesday, February 26th, 2014

Chinese Hurun Rich List : Eyal Ofer Is Richest Israeli

– – Eyal Ofer is the richest Israeli, with a fortune of $6.7 billion, followed by his brother, Idan Ofer, with a fortune of $5.4 billion, according to “Hurun”, the Chinese More...

Wordpress site Developed by Fixing WordPress Problems